Leap Therapeutics
LPTX
LPTX
49 hedge funds and large institutions have $59.9M invested in Leap Therapeutics in 2020 Q2 according to their latest regulatory filings, with 28 funds opening new positions, 13 increasing their positions, 1 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
2% more ownership
Funds ownership: 3.14% → 5.14% (+2%)
Holders
49
Holding in Top 10
–
Calls
$1.07M
Puts
–
Top Buyers
| 1 | +$7.53M | |
| 2 | +$5.69M | |
| 3 | +$3.61M | |
| 4 |
Alyeska Investment Group
Chicago,
Illinois
|
+$3.12M |
| 5 |
JGC
J. Goldman & Co
New York
|
+$2.13M |
Top Sellers
| 1 | -$79K | |
| 2 | -$45K | |
| 3 | -$42K | |
| 4 |
Victory Capital Management
San Antonio,
Texas
|
-$14K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
-$5.99K |